Zhu, Rui <br/><br/>
The pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazid.  [electronic resource] 

 -  Journal of clinical pharmacology  Apr 2012 
 - 511-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1552-4604 
<br/><br/><label>Standard No.: </label>10.1177/0091270011402826  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Age Factors<br/>Antitubercular Agents--administration & dosage<br/>Arylamine N-Acetyltransferase--genetics<br/>Child, Preschool<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Genotype<br/>HIV Infections--transmission<br/>Humans<br/>Infant<br/>Infectious Disease Transmission, Vertical<br/>Isoniazid--administration & dosage<br/>Latent Tuberculosis--prevention & control<br/>Male<br/>Pharmacogenetics<br/>Pregnancy<br/>Pregnancy Complications, Infectious--epidemiology<br/>Prospective Studies<br/>South Africa<br/>Tuberculosis--prevention & control